Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1984 Jul 1;160(1):303-9.
doi: 10.1084/jem.160.1.303.

Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule

AboT, A B Tilden, C M Balch, K Kumagai, G M Troup, M D Cooper
Comparative Study

Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule

AboT et al. J Exp Med. .

Abstract

The mitogenic effects of isotypically diverse antibodies to the T3 molecule were examined in genetically diverse population groups. Whereas the OKT3 antibody (IgG2a) was mitogenic for blood mononuclear cells from all individuals tested, the 38.1 antibody (IgM) was consistently nonmitogenic. In contrast, studies of the mitogenic effects of the Leu-4 antibody (IgG1) revealed striking ethnic differences. More than 80% of Caucasians and Negroes were good Leu-4 responders, whereas most individuals of Asian origin, including Indian, Japanese, and Chinese, were either Leu-4 nonresponders or Leu-4 low responders. However, the majority of American Indians, as well as a significant minority of Chinese, were good responders. Cell separation studies confirmed that monocytes govern the different mitogenic effects of the anti-T3 antibodies. The results reveal interesting ethnic differences in monocyte accessory function probably mediated via the Fc-gamma receptor, in the stimulation of T lymphocytes by an IgG1 antibody against the T3 molecule.

PubMed Disclaimer

References

    1. J Immunol. 1980 Jun;124(6):2708-13 - PubMed
    1. J Natl Cancer Inst. 1980 Nov;65(5):1127-39 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1805-8 - PubMed
    1. J Immunol. 1982 Oct;129(4):1758-61 - PubMed
    1. Cell. 1982 Oct;30(3):735-43 - PubMed

Publication types